Feb 17, 2026 08:00AM
Feb 12, 2026 08:02AM
Feb 12, 2026 08:00AM
Nov 12, 2025 04:05PM
Nov 6, 2025 08:02AM
Nov 6, 2025 08:00AM
Sep 29, 2025 09:00AM Cue Biopharma names Usman Azam as new CEO effective September 29
Sep 29, 2025 09:00AM
Aug 13, 2025 08:00AM
Aug 12, 2025 04:05PM
Jul 16, 2025 08:00AM
Jul 16, 2025 08:00AM
Jul 1, 2025 04:05PM
Jul 1, 2025 04:05PM Cue Biopharma Provides Update on Most Advanced Clinical Stage Asset, CUE-101, Presented by Dr. Dimitrios Colevas at the DAVA 4th Hawaii Global Summit on Thoracic Malignancies
Jun 24, 2025 04:48PM
Jun 24, 2025 04:48PM
May 12, 2025 04:05PM
May 8, 2025 08:00AM
Apr 14, 2025 05:00PM
Apr 14, 2025 05:00PM
Mar 31, 2025 04:20PM Cue Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
Nov 14, 2024 04:05PM
Nov 14, 2024 08:00AM
Nov 8, 2024 01:31PM
Nov 8, 2024 01:30PM
Sep 9, 2024 08:03AM
Sep 9, 2024 08:00AM
Sep 3, 2024 08:00AM Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference
Aug 19, 2024 04:05PM
Jul 25, 2024 04:05PM
Jul 25, 2024 04:05PM
Jun 4, 2024 08:00AM
May 9, 2024 04:05PM
Apr 8, 2024 04:05PM
Nov 9, 2023 04:05PM Cue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
Nov 3, 2023 12:01PM
Nov 3, 2023 12:00PM
Sep 27, 2023 09:05AM
Sep 26, 2023 08:00AM
Aug 9, 2023 04:10PM
Jun 14, 2023 08:00AM
May 25, 2023 05:00PM Cue Biopharma Presents Positive Data Update from Ongoing Phase 1 Trials of CUE-101 for Recurrent/Metastatic HPV+ Head and Neck Squamous Cell Carcinoma at the 2023 American Society of Clinical Oncolo
May 9, 2023 04:35PM
May 8, 2023 08:00AM
Apr 25, 2023 08:05AM
Apr 25, 2023 08:00AM
Apr 25, 2023 08:00AM
Apr 12, 2023 08:02AM
Apr 12, 2023 08:00AM Cue Biopharma Welcomes Industry Veteran Mr. Patrick Verheyen to its Board of Directors
Apr 12, 2023 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All